The role of VE-cadherin in osteosarcoma cells
- PMID: 19760520
- DOI: 10.1007/s12253-009-9198-1
The role of VE-cadherin in osteosarcoma cells
Abstract
Osteosarcoma cells can generate vasculogenic-like, patterned networks to obtain nutrients and oxygen, which mimic some function of endothelial-like cells and facilitate tumor malignant progress. These cells also express vascular endothelial-cadherin (VE-cadherin), which is generally accepted as a strictly endothelial-specific transmembrane protein. However, its role is still relatively obscure in osteosarcoma cells. So we inhibit the VE-cadherin gene expression with siRNA in osteosarcoma cells (MG63), and culture those cells in three-dimensional medium, containing Type I collagen or Matrigel, to observe the role of VE-cadherin. Western blotting analysis show that sequence-specific siRNA can significantly decrease the expression of VE-cadherin in MG63 cell. After knockdown of VE-cadherin, osteosarcoma cells can't induced angiogenic sprout and form osteosarcoma-generated, endothelial-like networks. Our data indicate that VE-cadherin may be a positive and specific regulator not only in angiogenesis, but also in vasculogenic mimicry of osteosarcoma cells. And it can be considered as a new prospective option in the combining treatment of aggressive tumor with highly vascularity, including osteosarcoma.
Similar articles
-
Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2).Graefes Arch Clin Exp Ophthalmol. 2009 Mar;247(3):411-9. doi: 10.1007/s00417-008-1008-z. Epub 2008 Nov 29. Graefes Arch Clin Exp Ophthalmol. 2009. PMID: 19043732
-
HIF-1α induces VE-cadherin expression and modulates vasculogenic mimicry in esophageal carcinoma cells.World J Gastroenterol. 2014 Dec 21;20(47):17894-904. doi: 10.3748/wjg.v20.i47.17894. World J Gastroenterol. 2014. PMID: 25548487 Free PMC article.
-
VEGF-siRNA silencing induces apoptosis, inhibits proliferation and suppresses vasculogenic mimicry in osteosarcoma in vitro.Exp Oncol. 2008 Mar;30(1):29-34. Exp Oncol. 2008. PMID: 18438338
-
Jumping the barrier: VE-cadherin, VEGF and other angiogenic modifiers in cancer.Biol Cell. 2011 Dec 1;103(12):593-605. doi: 10.1042/BC20110069. Biol Cell. 2011. PMID: 22054419 Review.
-
VE-Cadherin in Cancer-Associated Angiogenesis: A Deceptive Strategy of Blood Vessel Formation.Int J Mol Sci. 2023 May 26;24(11):9343. doi: 10.3390/ijms24119343. Int J Mol Sci. 2023. PMID: 37298296 Free PMC article. Review.
Cited by
-
Tissue engineered models of healthy and malignant human bone marrow.Adv Drug Deliv Rev. 2019 Feb 1;140:78-92. doi: 10.1016/j.addr.2019.04.003. Epub 2019 Apr 17. Adv Drug Deliv Rev. 2019. PMID: 31002835 Free PMC article. Review.
-
Understanding and Modeling Metastasis Biology to Improve Therapeutic Strategies for Combating Osteosarcoma Progression.Front Oncol. 2020 Jan 31;10:13. doi: 10.3389/fonc.2020.00013. eCollection 2020. Front Oncol. 2020. PMID: 32082995 Free PMC article. Review.
-
Relevance of 3d culture systems to study osteosarcoma environment.J Exp Clin Cancer Res. 2018 Jan 5;37(1):2. doi: 10.1186/s13046-017-0663-5. J Exp Clin Cancer Res. 2018. PMID: 29304852 Free PMC article. Review.
-
Prognostic significance and mechanisms of patterned matrix vasculogenic mimicry in hepatocellular carcinoma.Med Oncol. 2011 Dec;28 Suppl 1:S228-38. doi: 10.1007/s12032-010-9706-x. Epub 2010 Oct 19. Med Oncol. 2011. PMID: 20957524
-
Antitumor effects and mechanisms of pyropheophorbide‑α methyl ester‑mediated photodynamic therapy on the human osteosarcoma cell line MG‑63.Int J Mol Med. 2020 Apr;45(4):971-982. doi: 10.3892/ijmm.2020.4494. Epub 2020 Feb 10. Int J Mol Med. 2020. PMID: 32124948 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical